Skip to search formSkip to main contentSkip to account menu

Coxsackievirus A4 Ab:ACnc:Pt:CSF:Qn

Known as: Coxsackievirus A4 , Ac:Concentration arbitraire:Temps ponctuel:LCR:Quantitatif, [anticuerpo anti - ] virus Coxsackie A4 [Ac]:concentración arbitraria:punto en el tiempo:líquido cefalorraquídeo:cuantitativo, ????? A4 ? ??:?????:???:???:??? 
National Institutes of Health

Related topics

Related topics

6 relations
ACncAntibodiesCerebrospinal FluidCoxsackie Viruses

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development.
BACKGROUND One of the most studied anti-cancer compounds of the last several decades is the microtubule targeting agent and cis… 
Review
2017
Review
2017
Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development.
One of the most studied anti-cancer compounds of the last several decades is the microtubule targeting agent and cis-stilbene… 
2016
2016
Abstract 4839: Design of a Rofecoxib-Combretastatin hybrid drug that exerts highly potent antimicrotubule, anti-angiogenesis properties and Cox-2 inhibition both in cell culture and xenograft models
Given the molecular complexity of cancers, including the extreme heterogeneity in their genetic makeup, their plasticity, innate… 
2015
2015
HYS-32-Induced Microtubule Catastrophes in Rat Astrocytes Involves the PI3K-GSK3beta Signaling Pathway
HYS-32 is a novel derivative of combretastatin-A4 (CA-4) previously shown to induce microtubule coiling in rat primary astrocytes… 
2013
2013
Barnig Activation in Asthma Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell 4 Lipoxin
breathe easy. may help severe asthmatics 4 asthmatics, suggesting this as a new line of potential therapies. Increasing lipoxin A… 
2009
2009
1,4-Diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) Enhances the Cytotoxicity of Combretastatin A4 Independently of Mitogen-Activated Protein Kinase Kinase
Combretastatin A4 (CA4) is a novel vascular-disrupting agent that has shown promising anticancer effects through its inhibition… 
2007
2007
Combretastatin A 4-Induced Differential Cytotoxicity and Reduced Metastatic Ability by Inhibition of AKT Function in Human Gastric Cancer Cells
Combretastatin A4 (CA4) is a drug that targets tumor vasculature to inhibit angiogenesis. Whether CA4 has a direct effect on… 
2007
2007
Pharmacokinetics, Safety, and Hydrolysis of Oral Pyrroloquinazolinediamines Administered in Single and Multiple Doses in Rats
ABSTRACT Pyrroloquinazolinediamine (PQD) derivatives such as tetra-acetamide PQD (PQD-A4) and bis-ethylcarbamyl PQD (PQD-BE) were… 
2007
2007
Studies on Photolysis Kinetics of Combretastatin A4 Phosphate Solution
OBJECTIVE To study photolysis kinetics of combretastatin A4 phosphate solution.METHODS CA4P solution was exposed to different… 
2002
2002
Characterization of native and recombinant A4 glyceraldehyde 3-phosphate dehydrogenase. Kinetic evidence for confromation changes upon association with the small protein CP12.
A4 glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was purified from the green alga Chlamydomonas reinhardtii and was also… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)